Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis

Published:2020-09-01 Issue:9 Volume:16 Page:931-942
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Liakouli Vasiliki¹,Ciaffi Jacopo²,Ursini Francesco²³,Ruscitti Piero⁴,Meliconi Riccardo²³,Ciccia Francesco¹,Cipriani Paola⁴,Giacomelli Roberto⁴^ORCID

Affiliation:

1. Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

2. IRRCS Istituto Ortopedico Rizzoli, Bologna, Italy

3. Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy

4. Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2020.1813569

Reference65 articles.

1. Systemic sclerosis

2. Changes in causes of death in systemic sclerosis, 1972-2002

3. Mapping and predicting mortality from systemic sclerosis

4. Interstitial lung disease in systemic sclerosis: current and future treatment

5. Interstitial Lung Disease in Systemic Sclerosis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update of the guidelines for sclerosing skin diseases;Journal of the European Academy of Dermatology and Venereology;2024-06-25

2. Novel and potential future therapeutic options in systemic autoimmune diseases;Frontiers in Immunology;2024-03-15

3. Management of Progressive Skin Involvement in Diffuse Scleroderma;Scleroderma;2024

4. Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis;Expert Review of Clinical Immunology;2023-06-29

5. Esclerodermia sistémica: tratamiento;EMC - Aparato Locomotor;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3